Manulife (Manufacturers Life Insurance)’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $51.8K | Sell |
20,979
-3,945
| -16% | -$9.74K | ﹤0.01% | 2884 |
|
2025
Q1 | $49.6K | Buy |
24,924
+1,332
| +6% | +$2.65K | ﹤0.01% | 2834 |
|
2024
Q4 | $68.9K | Buy |
23,592
+197
| +0.8% | +$575 | ﹤0.01% | 2888 |
|
2024
Q3 | $90.5K | Sell |
23,395
-743
| -3% | -$2.88K | ﹤0.01% | 2887 |
|
2024
Q2 | $124K | Sell |
24,138
-50,790
| -68% | -$261K | ﹤0.01% | 2769 |
|
2024
Q1 | $524K | Buy |
74,928
+10,381
| +16% | +$72.7K | ﹤0.01% | 2193 |
|
2023
Q4 | $572K | Sell |
64,547
-113
| -0.2% | -$1K | ﹤0.01% | 2120 |
|
2023
Q3 | $617K | Buy |
64,660
+6,259
| +11% | +$59.7K | ﹤0.01% | 2028 |
|
2023
Q2 | $856K | Buy |
58,401
+12,770
| +28% | +$187K | ﹤0.01% | 1742 |
|
2023
Q1 | $561K | Buy |
45,631
+642
| +1% | +$7.9K | ﹤0.01% | 1939 |
|
2022
Q4 | $887K | Buy |
+44,989
| New | +$887K | ﹤0.01% | 1670 |
|